TheEdgeResearch
Home / Stocks / GNRS

The Greenrose Holding Company Inc. (GNRS)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▼ -50.00%
Market Cap
$1,768
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-170.34
52-Wk Range
1.0E-4-0.2825
CEO
Nicole Conboy
Country
US
Currency
USD

The Greenrose Holding Company Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Amityville, NY, US. The stock last traded at $0.00, down 50.00% on the session, giving a market capitalisation of $1,768. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 70.6%. Its beta of -170.34 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
4.51
Gross margin
59.1%
Operating margin
38.7%
Net margin
70.6%
Return on equity
—
Debt / equity
1.57
Current ratio
0.21
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
91
IPO date
2020-05-21
Headquarters
Amityville, NY, US
About The Greenrose Holding Company Inc.

Established in 2014 and headquartered in Amityville, New York, The Greenrose Holding Company Inc. operates via its subsidiaries to manufacture and distribute cannabis products. Its core business involves the cultivation, processing, and packaging of medical cannabis and related derivative items.

Comparable companies

The Greenrose Holding Company Inc. is most often compared with the following Healthcare names:

BLEVFEPRSQGWHPINTPMLTOORVRFRXEITAUGWLNSFXCRP
More research on GNRS
GNRS technical analysis GNRS TheEdge Score Compare against peers
Open full interactive analysis & DCF →